FindTrial
Sign In

The value of high-density lipoprotein levels in the diagnosis and prognosis of patients with sepsis

The value of high-density lipoprotein levels in the diagnosis and prognosis of patients with sepsis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019793
Enrollment
Unknown
Registered
2018-11-29
Start date
2018-12-01
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

sepsis group:sepsis parents
non-sepsis group:non-sepsis parents

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Diagnosed as sepsis or septic shock, with the third international consensus (sepsis-3.0) defined in 2016 on sepsis and septic shock as the diagnostic criteria, diagnosed by two or more attending physicians

Exclusion criteria

Exclusion criteria: (1) cirrhosis, end stage renal disease, advanced cancer, history of hyperlipidemia or total parenteral nutrition at the time of blood collection; (2) use of drugs that affect lipid metabolism (lipophilic agents, corticosteroids, non-steroidal anti-inflammatory; (3) patients with thyroid metabolic disorders; (4) immunosuppression (ie AIDS, neutropenia, chemotherapy. ICU before admission to hemodialysis, malnutrition); (5) during hospitalization <24h.

Design outcomes

Primary

MeasureTime frame
High density lipoprotein;—

Countries

China

Contacts

Public ContactZhao Wenjing

Affiliated Hospital of Xuzhou Medical University

zhaowj886@sina.com+86 13852157285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026